Research ArticleArticle
Use of Chimeric Enzymes and Site-Directed Mutagenesis for Identification of Three Key Residues Responsible for Differences in Steroid Hydroxylation between Canine Cytochromes P-450 3A12 and 3A26
David J. Fraser, You Qun He, Greg R. Harlow and James R. Halpert
Molecular Pharmacology February 1999, 55 (2) 241-247; DOI: https://doi.org/10.1124/mol.55.2.241
David J. Fraser
Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona
You Qun He
Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona
Greg R. Harlow
Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona
James R. Halpert
Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Use of Chimeric Enzymes and Site-Directed Mutagenesis for Identification of Three Key Residues Responsible for Differences in Steroid Hydroxylation between Canine Cytochromes P-450 3A12 and 3A26
David J. Fraser, You Qun He, Greg R. Harlow and James R. Halpert
Molecular Pharmacology February 1, 1999, 55 (2) 241-247; DOI: https://doi.org/10.1124/mol.55.2.241
Research ArticleArticle
Use of Chimeric Enzymes and Site-Directed Mutagenesis for Identification of Three Key Residues Responsible for Differences in Steroid Hydroxylation between Canine Cytochromes P-450 3A12 and 3A26
David J. Fraser, You Qun He, Greg R. Harlow and James R. Halpert
Molecular Pharmacology February 1, 1999, 55 (2) 241-247; DOI: https://doi.org/10.1124/mol.55.2.241
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement